Pacer Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.24M | Sell |
386,629
-215,039
| -36% | -$5.14M | 0.02% | 501 |
|
|
2025
Q1 | $15M | Sell |
601,668
-2,661,169
| -82% | -$66.1M | 0.04% | 359 |
|
|
2024
Q4 | $61.5M | Sell |
3,262,837
-1,699,384
| -34% | -$32M | 0.13% | 171 |
|
|
2024
Q3 | $74.7M | Buy |
4,962,221
+2,799,434
| +129% | +$42.1M | 0.16% | 158 |
|
|
2024
Q2 | $61.9M | Buy |
2,162,787
+590,082
| +38% | +$16.9M | 0.14% | 175 |
|
|
2024
Q1 | $46M | Buy |
1,572,705
+531,026
| +51% | +$15.5M | 0.11% | 207 |
|
|
2023
Q4 | $35.1M | Buy |
1,041,679
+1,041,417
| +397,487% | +$35.1M | 0.1% | 220 |
|
|
2023
Q3 | $8.04K | Sell |
262
-10
| -4% | -$307 | ﹤0.01% | 2578 |
|
|
2023
Q2 | $10.9K | Buy |
+272
| New | +$10.9K | ﹤0.01% | 3370 |
|